On Invalid Date, Tempest Therapeutics (NASDAQ: TPST) reported Q1 2023 earnings per share (EPS) of -$0.55, up 53.39% year over year. Total Tempest Therapeutics earnings for the quarter were -$7.64 million. In the same quarter last year, Tempest Therapeutics's earnings per share (EPS) was -$1.18.
As of Q2 2023, Tempest Therapeutics's earnings has grown year over year. Tempest Therapeutics's earnings in the past year totalled -$34.85 million.
What was TPST's revenue last quarter?
On Invalid Date, Tempest Therapeutics (NASDAQ: TPST) reported Q1 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Tempest Therapeutics's revenue was $0.00.
What was TPST's revenue growth in the past year?
As of Q2 2023, Tempest Therapeutics's revenue has grown null year over year. Tempest Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.